Trial Profile
Phase II Randomized Multicenter Study Comparing Brain Radiation in Combination With Temozolomide or Radiation Alone in Patients With Brain Metastases From Breast Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Advanced breast cancer; Cancer metastases
- Focus Therapeutic Use
- 14 Dec 2013 Status changed from recruiting to completed.
- 14 Dec 2013 Results presented at the 36th Annual San Antonio Breast Cancer Symposium.
- 10 Dec 2011 Results presented at the 34th Annual San Antonio Breast Cancer Symposium.